Status:

COMPLETED

Outcome of Botulinum Toxin Treatment for Oromandibular Dystonia

Lead Sponsor:

Fondation Ophtalmologique Adolphe de Rothschild

Conditions:

Dystonia; Orofacial

Eligibility:

All Genders

18+ years

Brief Summary

Symptoms of oromandibular dystonia can be alleviated by injections of botulinum toxin. The scope of this study is to describe the efficacy of this procedure, by a retrospective systematic review of pa...

Eligibility Criteria

Inclusion

  • Patient suffering from oromandibular dystonia
  • Medical follow up in the Fondation Ophtalmologique Rothschild (Paris)
  • Treatment by at least one session of botulinum toxin injection

Exclusion

  • Patient cannot assess symptoms improvement using a Likert scale

Key Trial Info

Start Date :

January 1 2016

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 12 2016

Estimated Enrollment :

240 Patients enrolled

Trial Details

Trial ID

NCT03363113

Start Date

January 1 2016

End Date

July 12 2016

Last Update

December 6 2017

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Outcome of Botulinum Toxin Treatment for Oromandibular Dystonia | DecenTrialz